Total Matching Records found : 29

Covaxin not to be used in cases of allergy, fever, poor immunity -Bindu Shajan Perappadan

-The Hindu Company releases fact sheet detailing possible adverse events and those who are eligible for the vaccine Those with any history of allergies, fever and bleeding disorder, on blood thinners and who are immunity compromised or on medication have been told by COVAXIN manufacturer Bharat Biotech not to take the vaccine. A statement uploaded on the company website on Monday said the vaccine was also contraindicated for pregnant/lactating women, those using other...

More »

Experts raise questions over ‘hasty’ approval for COVID-19 vaccines -Jacob Koshy

-The Hindu They advise against Covaxin, say there is no proof of efficacy. Several experts have raised concern over the “hasty approval” granted to the COVID-19 vaccines despite the lack of adequate efficacy data. The Central Drugs Standard Control Organisation on Sunday accorded approval for restricted emergency use of the Oxford COVID-19 vaccine Covishield, manufactured by the Serum Institute of India (SII), and the indigenously developed vaccine Covaxin of Bharat Biotech. “I’m completely unaware...

More »

How India plans to ensure safety and efficacy of covid-19 vaccines -Neetu Chandra Sharma India has adopted a cautious approach in granting approval to covid-19 vaccines as fast tracking, safety and efficacy remain primary concern NEW DELHI: Safety and efficacy are the primary concerns of the government while granting emergency use authorization (EUA) to any covid-19 vaccine in the country. The government's cautious approach before approving a vaccine is apparent. The meeting of the subject expert committee of Central Drugs Standards Control Organisation on Wednesday asked...

More »

More than a vaccine, it is about vaccination -T Jacob John and MS Seshadri

-The Hindu As a COVID-19 vaccine is for all age groups, putting in place an innovative delivery platform in time is a must Everyone eagerly asks: will we get a COVID-19 vaccine this year or only next year? During a pandemic, expecting vaccines the same year or the next, illustrates the power of technology, human hope, media hype — all at unprecedented frenzy. Where India stands Globally, innumerable vaccine trials are progressing; in India,...

More »

Completion of trials could take at least 6 to 9 months, says Soumya Swaminathan -R Prasad

-The Hindu It is encouraging to see that at least seven Indian companies are developing COVID-19 vaccines. All of them must be tested ... and till we see results from these trials, we cannot predict which of them will be successful, says the Chief Scientist at WHO A day after scientists and experts raised serious concerns over Indian Council of Medical Research’s (ICMR) letter to all 12 principal investigators to speed up...

More »

Video Archives


share on Facebook
Read Later

Contact Form

Please enter security code